M. Savić, “Neurotoxicity De-Risking in Preclinical Drug Discovery”, arhfarm, vol. 72, no. Suppl. 4, pp. S163-S164, Oct. 2022, Accessed: Jul. 12, 2026. [Online]. Available: https://asistent.ceon.rs/index.php/arhfarm/article/view/38997